Elevance Health Forecasts Revenue Decline and Lower Profit for 2026
Elevance Health issued a cautious 2026 outlook with lower revenue and profit targets. The forecast sent shares down as rising medical costs pressure the sector.
Insights:
Elevance Health, Inc. announced on January 28, 2026, that it expects total operating revenue in the US 
USto decline by a low-single-digit percentage range for the 2026 fiscal year. The insurer forecasted an adjusted profit of at least $25.50 per share, which falls short of the $26.90 per share expected by Wall Street analysts. This outlook triggered a significant market reaction, as shares of Elevance Health, Inc.dropped more than 7% in pre-market trading following the announcement.
USto decline by a low-single-digit percentage range for the 2026 fiscal year. The insurer forecasted an adjusted profit of at least $25.50 per share, which falls short of the $26.90 per share expected by Wall Street analysts. This outlook triggered a significant market reaction, as shares of Elevance Health, Inc.dropped more than 7% in pre-market trading following the announcement.Led by Chief Executive Officer Gail Boudreaux gail boudreaux, the company noted that the 2026 forecast reflects a low-double-digit decline in membership across certain plans. These losses are expected to be partially offset by higher premiums and growth within Carelon, the health services business of Elevance Health, Inc.. The guidance points toward a front-loaded year, with the company projecting to earn approximately two-thirds of its annual adjusted earnings during the first half of 2026.
